지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.5
- 수록면
- 1,137 - 1,149 (13page)
- DOI
- 10.1038/s12276-024-01221-2
이용수
초록· 키워드
오류제보하기
Osimertinib, a selective third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), effectively targets the EGFR T790M mutant in non-small cell lung cancer (NSCLC). However, the newly identified EGFR C797S mutation confers resistance to osimertinib. In this study, we explored the role of pyruvate dehydrogenase kinase 1 (PDK1) in osimertinib resistance. Patients exhibiting osimertinib resistance initially displayed elevated PDK1 expression. Osimertinib-resistant cell lines with the EGFR C797S mutation were established using A549, NCI-H292, PC-9, and NCI-H1975 NSCLC cells for both in vitro and in vivo investigations. These EGFR C797S mutant cells exhibited heightened phosphorylation of EGFR, leading to the activation of downstream oncogenic pathways. The EGFR C797S mutation appeared to increase PDK1-driven glycolysis through the EGFR/AKT/HIF-1α axis. Combining osimertinib with the PDK1 inhibitor leelamine helped successfully overcome osimertinib resistance in allograft models. CRISPR-mediated PDK1 knockout effectively inhibited tumor formation in xenograft models. Our study established a clear link between the EGFR C797S mutation and elevated PDK1 expression, opening new avenues for the discovery of targeted therapies and improving our understanding of the roles of EGFR mutations in cancer progression.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Dual effects of a CpG-DNAzyme targeting mutant EGFR transcripts in lung cancer cells: TLR9 activation and EGFR downregulation
BMB Reports
2018 .01
-
Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective
BMB Reports
2020 .01
-
Cell-based Biosensor for the Detection of Ligand-induced EGFR Dimerization
한국생물공학회 학술대회
2022 .09
-
Mutations in the tyrosine kinase domain of the EGFR gene are rare in the Korean Oral Squamous Cell Carcinoma
한국컴퓨터정보학회논문지
2016 .09
-
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer
Experimental and Molecular Medicine
2019 .01
-
Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
BMB Reports
2015 .01
-
비소세포폐암 EGFR유전자 변이 검출용 액체생검 카트리지 및 사출 금형 설계 기술 개발
한국소성가공학회 학술대회 논문집
2023 .11
-
Pyruvate dehydrogenase kinase 1 and 2 deficiency reduces high-fat diet-induced hypertrophic obesity and inhibits the differentiation of preadipocytes into mature adipocytes
Experimental and Molecular Medicine
2021 .09
-
BIX01294 inhibits EGFR signaling in EGFR-mutant lung adenocarcinoma cells through a BCKDHA-mediated reduction in the EGFR level
Experimental and Molecular Medicine
2021 .12
-
Development of EGFR Specific DNA Aptamer for Cell Culture Medium Supplements
한국생물공학회 학술대회
2015 .10
-
조영제 증강 CT 검사 환자에서 eGFR 을 적용한 부작용 분석
방사선산업학회지
2019 .01
-
In Vitro Selection of EGFR Specific DNA Aptamer for Serum-free Cell Culture Medium Supplements
한국생물공학회 학술대회
2015 .04
-
Serine 389 phosphorylation of 3-phosphoinositide-dependent kinase 1 by UNC-51-like kinase 1 affects its ability to regulate Akt and p70 S6kinase
BMB Reports
2020 .01
-
TRAIL and EGFR Affibody Dual-displayed Lumazine Synthase Protein Cage Enhance Tumorspecific Cell Apoptosis
한국생물공학회 학술대회
2020 .06
-
Drug evaluation based on phosphomimetic PDHA1 reveals the complexity of activity-related cell death in A549 non-small cell lung cancer cells
BMB Reports
2021 .11
-
Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
Experimental and Molecular Medicine
2020 .01
-
EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide
Experimental and Molecular Medicine
2020 .08
최근 본 자료
댓글(0)
0